Edition:
United Kingdom

Kazia Therapeutics Ltd (KZIA.OQ)

KZIA.OQ on NASDAQ Stock Exchange Capital Market

2.54USD
15 Dec 2017
Change (% chg)

$0.24 (+10.43%)
Prev Close
$2.30
Open
$2.31
Day's High
$2.58
Day's Low
$2.28
Volume
2,929
Avg. Vol
1,147
52-wk High
$7.56
52-wk Low
$2.28

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Jun '17 0.11 -0.013
Dec 0.14 -0.037
FY 2016 Jun '16 0.24 -0.077
Dec 0.17 -0.036
FY 2015 Jun '15 0.08 -0.065
Dec 0.01 -0.051
 
*Note: Units in Millions ofAustralian Dollars
**Note: Units in Australian Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Jun-17 1 0.14 0.14 0.14 --
Year Ending Jun-18 1 7.35 7.35 7.35 0.00
Year Ending Jun-19 1 17.31 17.31 17.31 0.00
Earnings (per share)
Year Ending Jun-17 1 -12.00 -12.00 -12.00 --
Year Ending Jun-18 1 -351.27 -351.27 -351.27 -16.00
Year Ending Jun-19 1 -219.23 -219.23 -219.23 -24.00
Sales and Profit Figures in Australian Dollar (AUD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 88.66 32.93
P/E High - Last 5 Yrs. -- 290.77 45.62
P/E Low - Last 5 Yrs. -- 93.67 24.34
Beta -0.08 0.85 0.88
Price to Sales (TTM) 79.63 100.68 5.40
Price to Book (MRQ) 0.18 13.50 5.38
Price to Tangible Book (MRQ) 2.10 13.43 6.78
Price to Cash Flow (TTM) -- 76.24 23.45
% Owned Institutions 1.59 6.25 1.40

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.50
Dividend Yield - 5 Year Avg -- 0.28 1.52
Dividend 5 Year Growth Rate -- 1.88 5.17
Payout Ratio(TTM) -- 17.26 43.76

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -55.57 433.88 9.00
Sales (TTM) vs TTM 1 Yr. Ago -38.66 75.04 5.38
Sales - 5 Yr. Growth Rate -29.68 33.47 10.33
EPS (MRQ) vs Qtr. 1 Yr. Ago 82.47 30.81 19.67
EPS (TTM) vs TTM 1 Yr. Ago 55.28 -- --
EPS - 5 Yr. Growth Rate -- 43.18 10.79
Capital Spending - 5 Yr. Growth Rate 63.40 40.71 15.25

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.68 2.18
Current Ratio (MRQ) 3.62 5.36 2.98
LT Debt to Equity (MRQ) 0.00 18.93 11.56
Total Debt to Equity (MRQ) 0.00 20.59 15.81
Interest Coverage (TTM) -381,217.00 -111.94 33.29

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 38.73 54.83
Gross Margin - 5 Yr. Avg. -- 51.18 52.40
EBITD Margin (TTM) -6,924.99 -- --
EBITD - 5 Yr. Avg -2,506.94 -261.13 15.24
Operating Margin (TTM) -7,495.51 -556.69 7.76
Operating Margin - 5 Yr. Avg. -2,718.78 -279.31 10.75
Pre-Tax Margin (TTM) -4,367.83 -529.93 8.57
Pre-Tax Margin - 5 Yr. Avg. -2,028.72 -279.05 11.17
Net Profit Margin (TTM) -4,288.05 -531.37 4.88
Net Profit Margin - 5 Yr. Avg. -2,018.50 -282.22 7.47
Effective Tax Rate (TTM) -- 23.72 23.11
Effective Tax Rate - 5 Yr. Avg. -- 19.13 24.00

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 25,316,769 864,680,848
Net Income/Employee (TTM) -- 3,332,346 101,718,394
Receivable Turnover (TTM) 0.11 21.54 5.76
Inventory Turnover (TTM) -- 2.01 3.34
Asset Turnover (TTM) 0.01 0.37 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -29.88 -0.77 11.00
Return on Assets - 5 Yr. Avg. -34.24 -0.26 12.43
Return on Investment (TTM) -33.03 2.36 14.46
Return on Investment - 5 Yr. Avg. -38.70 2.98 16.28
Return on Equity (TTM) -36.01 2.96 16.05
Return on Equity - 5 Yr. Avg. -39.42 6.41 17.51
  1 Year 3 Year 5 Year
Sales % -38.66 42.12 -29.68
EPS (TTM) % 79.79 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Kazia Therapeutics Ltd

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 1.60%
# of Holders: 5
Total Shares Held: 77,316
3 Mo. Net Change: 320
# New Positions: 0
# Closed Positions: 2
# Increased Positions: 3
# Reduced Positions: 2
# Net Buyers: 1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.